Use of ACE inhibitors was similar for both stroke patients with pneumonia and matched-controls; ACE inhibitors did not confer any decreased risk of pneumonia (OR, 0.9; 95% CI, 0.2–3.0) Here, ACE is linked to susceptibility to pneumonia measurement.